Zhu CY - Search Results

1

Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.

Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, Tseng CH, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Livhits MJ, et al. Among authors: zhu cy. JAMA Oncol. 2021 Jan 1;7(1):70-77. doi: 10.1001/jamaoncol.2020.5935. JAMA Oncol. 2021. PMID: 33300952 Free PMC article. Clinical Trial.

2

Who Benefits from Treatment of Primary Hyperparathyroidism?

Zhu CY, Nguyen DT, Yeh MW. Zhu CY, et al. Surg Clin North Am. 2019 Aug;99(4):667-679. doi: 10.1016/j.suc.2019.04.007. Epub 2019 May 11. Surg Clin North Am. 2019. PMID: 31255198 Review.

3

The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients With Hypothyroidism.

Shirali AS, Wu JX, Zhu CY, Ocampo A, Tseng CH, Du L, Livhits MJ, Leung AM, Yeh MW. Shirali AS, et al. Among authors: zhu cy. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5915-5922. doi: 10.1210/jc.2019-01082. J Clin Endocrinol Metab. 2019. PMID: 31361312

4

Skeletal effects of combined medical and surgical management of primary hyperparathyroidism.

Orr LE, Zhou H, Zhu CY, Haigh PI, Adams AL, Yeh MW. Orr LE, et al. Among authors: zhu cy. Surgery. 2020 Jan;167(1):144-148. doi: 10.1016/j.surg.2019.04.059. Epub 2019 Sep 30. Surgery. 2020. PMID: 31582307

5

Diagnosis and Management of Primary Hyperparathyroidism.

Zhu CY, Sturgeon C, Yeh MW. Zhu CY, et al. JAMA. 2020 Mar 24;323(12):1186-1187. doi: 10.1001/jama.2020.0538. JAMA. 2020. PMID: 32031566 Review. No abstract available.

6

[No title available]

[No authors listed] [No authors listed] PMID: 32407663

7

Trends in the Surgical Management of Known or Suspected Differentiated Thyroid Cancer at a Single Institution, 2010-2018.

Zhu CY, Sha SW, Tseng CH, Yang SE, Orr LE, Levin M, Wong CW, Livhits MJ, Rao J, Yeh MW. Zhu CY, et al. Thyroid. 2020 Nov;30(11):1639-1645. doi: 10.1089/thy.2019.0783. Epub 2020 Jul 10. Thyroid. 2020. PMID: 32515290

8

Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules.

Chin PD, Zhu CY, Sajed DP, Fishbein GA, Yeh MW, Leung AM, Livhits MJ. Chin PD, et al. Among authors: zhu cy. Endocr Pathol. 2020 Dec;31(4):377-384. doi: 10.1007/s12022-020-09641-2. Epub 2020 Jul 15. Endocr Pathol. 2020. PMID: 32671653

9

Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.

Zhu CY, Donangelo I, Gupta D, Nguyen DT, Ochoa JE, Yeh MW, Livhits MJ. Zhu CY, et al. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1240-e1247. doi: 10.1210/clinem/dgaa887. J Clin Endocrinol Metab. 2021. PMID: 33394039

10

Quality of Life Following Molecular Marker Testing for Indeterminate Thyroid Nodules.

Wong CW, Schumm MA, Zhu CY, Tseng CH, Arasu A, Han J, Livhits MJ. Wong CW, et al. Among authors: zhu cy. Endocr Pract. 2020 Sep;26(9):960-966. doi: 10.4158/EP-2020-0101. Endocr Pract. 2020. PMID: 33471700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters